Advanced search×

Entitlement to hospital treatment in the NHS.

Duncan Edwards and David A Barr

Br J Hosp Med (Lond) 72(3):124-5 (2011) PMID 21475089

In 1977 powers to charge those not 'ordinarily resident' in the UK for NHS care were first introduced, and rules governing eligibility for free NHS care have become increasingly complex since. In this issue (p. 156), Dubrey et al present an interpretation of the current regulations and express concern that the treatment of ineligible patients presents a threat to the UK health system. Here we suggest the opposite: increasing attempts to restrict the access of vulnerable humans to health care present a threat both to individual and public health. We challenge all clinicians to provide immediately necessary care and to protect public health.

Version: za2963e q8za9 q8zbc q8zc6 q8zd2 q8ze8 q8zf4 q8zge

Similar articles you may find interesting…

  1. Long-term HIV infection and antiretroviral therapy are associated with bone microstructure alterations in premenopausal women
    A Calmy, T Chevalley, and R Rizzoli

    Osteoporos Int 24(6):1843-1852 (2013) PMID 23138338

    Compared with HIV-ve subjects, premenopausal HIV+ve treated women had trabecular and cortical bone alterations. Adjusted analysis revealed that HIV status was the only determinant of between group tibia trabecular density differences. The latter could contribute to increased bone fragility in HIV+ve...
  2. Keloid scars in type VI skin successfully treated with combined surgery and pulsed dye laser therapy
    U Eke, C Diaz, and A Abdullah

    Br J Dermatol 168(6):1360-1362 (2013) PMID 23252810

    We report on the successful use of surgical shave-excision followed by single-pass pulsed dye laser (PDL) therapy for the treatment of keloids scars in three men with type VI skin. In all cases, the Candela V Beam Perfecta pulsed dye laser (595mm) and incorporated Dynamic Cooling Device (TM) (DCD) w...
  3. Treatment of high risk Sertoli-Leydig cell tumors of the ovary using a gonadotropin releasing hormone (GnRH) analog
    Harsha Prasada Lashkari, Ruth Nash, and Kathy Pritchard-Jones

    Pediatr Blood Cancer 60(6):E16-E18 (2013) PMID 23193086

    We report two unusual cases with bilateral SLCTs suggesting evidence of genetic predisposition and at high risk of recurrence. To reduce this risk, we exploited the use of GnRH analog to lower gondadotropin and potentially directly inhibit the tumors through expressed GnRH receptors. We used it as m...